HIV Vaccine Development.

David I. Watkins

HIV Vaccine Development.

Research output: Contribution to journal › Article › peer-review

Abstract

Several interesting new vaccine-related studies were presented at the 16th Conference on Retroviruses and Opportunistic Infections this year. Transmitted viruses appear to be derived from cell-free virus rather than cell-associated virus, at least in men who have sex with men. Follow-up studies from the Step (HIV Vaccine Trials Network 502) trial indicated that if individuals mounted certain vaccine-induced responses, they may control viral replication after infection. Finally, adeno-associated-virus-derived neutralizing antibodies completely protected macaques from infection, suggesting novel mechanisms of viral control.

Original language	English (US)
Pages (from-to)	35-36
Number of pages	2
Journal	Topics in HIV medicine : a publication of the International AIDS Society, USA
Volume	17
Issue number	2
State	Published - Jan 1 2009
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e2a2014e66404377b966d96ea953e819,

title = "HIV Vaccine Development.",

abstract = "Several interesting new vaccine-related studies were presented at the 16th Conference on Retroviruses and Opportunistic Infections this year. Transmitted viruses appear to be derived from cell-free virus rather than cell-associated virus, at least in men who have sex with men. Follow-up studies from the Step (HIV Vaccine Trials Network 502) trial indicated that if individuals mounted certain vaccine-induced responses, they may control viral replication after infection. Finally, adeno-associated-virus-derived neutralizing antibodies completely protected macaques from infection, suggesting novel mechanisms of viral control.",

author = "Watkins, {David I.}",

year = "2009",

month = jan,

day = "1",

language = "English (US)",

volume = "17",

pages = "35--36",

journal = "Topics in antiviral medicine",

issn = "2161-5853",

publisher = "International Antiviral Society",

number = "2",

}

TY - JOUR

T1 - HIV Vaccine Development.

AU - Watkins, David I.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Several interesting new vaccine-related studies were presented at the 16th Conference on Retroviruses and Opportunistic Infections this year. Transmitted viruses appear to be derived from cell-free virus rather than cell-associated virus, at least in men who have sex with men. Follow-up studies from the Step (HIV Vaccine Trials Network 502) trial indicated that if individuals mounted certain vaccine-induced responses, they may control viral replication after infection. Finally, adeno-associated-virus-derived neutralizing antibodies completely protected macaques from infection, suggesting novel mechanisms of viral control.

AB - Several interesting new vaccine-related studies were presented at the 16th Conference on Retroviruses and Opportunistic Infections this year. Transmitted viruses appear to be derived from cell-free virus rather than cell-associated virus, at least in men who have sex with men. Follow-up studies from the Step (HIV Vaccine Trials Network 502) trial indicated that if individuals mounted certain vaccine-induced responses, they may control viral replication after infection. Finally, adeno-associated-virus-derived neutralizing antibodies completely protected macaques from infection, suggesting novel mechanisms of viral control.

UR - http://www.scopus.com/inward/record.url?scp=67650689821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650689821&partnerID=8YFLogxK

M3 - Article

C2 - 19401605

AN - SCOPUS:67650689821

VL - 17

SP - 35

EP - 36

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5853

IS - 2

ER -

HIV Vaccine Development.

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this